搜尋





搜尋





Cue Biopharma Inc

CUE

添加自選

40.430USD

+2.590+6.84%

交易中 09/18, 09:42（美東）

211.42M總市值

虧損本益比TTM

Cue Biopharma Inc

40.430

+2.590+6.84%

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

CUE 利潤表

您可以在這裡找到Cue Biopharma Inc的年度或季度收入報告，以深入了解Cue Biopharma Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

營業總收入

166.66%7.88M

1250.59%5.69M

1292.26%21.94M

-35.58%2.15M

11.14%2.95M

-75.48%421.00K

-13.45%1.58M

58.86%3.34M

92.33%2.66M

818.18%1.72M

1104.15%1.82M

2988.24%2.10M

5215.38%1.38M

-81.30%187.00K

-98.17%151.23K

-97.16%68.00K

-99.05%26.00K

-35.61%1.00M

1636.57%8.25M

240.20%2.40M

154.79%2.74M

72.56%1.55M

-54.70%475.32K

-28.46%704.00K

1.90%1.07M

143.24%900.00K

217.40%1.05M

119.15%984.00K

513.37%1.05M

--370.00K

--330.60K

--449.00K

--172.00K

--0.00

營業收入

166.66%7.88M

1250.59%5.69M

1292.26%21.94M

-35.58%2.15M

11.14%2.95M

-75.48%421.00K

-13.45%1.58M

58.86%3.34M

92.33%2.66M

818.18%1.72M

1104.15%1.82M

2988.24%2.10M

5215.38%1.38M

-81.30%187.00K

-98.17%151.23K

-97.16%68.00K

-99.05%26.00K

-35.61%1.00M

1636.57%8.25M

240.20%2.40M

154.79%2.74M

72.56%1.55M

-54.70%475.32K

-28.46%704.00K

1.90%1.07M

143.24%900.00K

217.40%1.05M

119.15%984.00K

513.37%1.05M

--370.00K

--330.60K

--449.00K

--172.00K

--0.00

營業費用

724.68%95.57M

-13.14%11.05M

78.35%19.98M

-20.86%9.69M

-11.13%11.59M

-11.57%12.72M

-27.69%11.21M

-9.40%12.25M

-12.47%13.04M

6.03%14.38M

3.06%15.50M

21.80%13.52M

11.40%14.90M

-10.97%13.57M

-6.89%15.04M

-27.99%11.10M

2.55%13.37M

8.29%15.24M

41.03%16.15M

42.25%15.41M

8.53%13.04M

1.27%14.07M

13.76%11.45M

34.13%10.84M

16.83%12.02M

17.78%13.89M

-10.91%10.06M

-38.84%8.08M

34.56%10.29M

56.83%11.80M

8.22%11.30M

162.48%13.21M

73.21%7.64M

124.54%7.52M

267.26%10.44M

148.59%5.03M

--4.41M

--3.35M

--2.84M

--2.02M

研發費用

519.23%48.98M

-20.11%6.83M

129.27%16.47M

-49.32%4.75M

-17.00%7.91M

-16.20%8.55M

-34.01%7.18M

-3.76%9.38M

-9.41%9.53M

10.59%10.20M

-3.93%10.89M

32.18%9.75M

12.14%10.52M

-5.92%9.22M

1.05%11.33M

-32.94%7.38M

10.72%9.38M

2.89%9.80M

44.30%11.21M

51.18%11.00M

7.62%8.47M

-1.45%9.53M

12.58%7.77M

43.73%7.27M

18.78%7.87M

18.53%9.67M

4.15%6.90M

-50.02%5.06M

26.75%6.63M

44.10%8.16M

-25.51%6.63M

160.83%10.13M

57.58%5.23M

136.13%5.66M

343.88%8.90M

188.75%3.88M

--3.32M

--2.40M

--2.00M

--1.34M

折舊攤銷及損耗

-64.00%36.00K

460.40%566.00K

591.84%678.00K

-22.33%80.00K

-2.91%100.00K

2.02%101.00K

-13.27%98.00K

-21.37%103.00K

-24.26%103.00K

-44.07%99.00K

-44.40%113.00K

-34.83%131.00K

-36.74%136.00K

-41.58%177.00K

-34.37%203.24K

-36.39%201.00K

-31.53%215.00K

-4.72%303.00K

22.17%309.66K

17.47%316.00K

15.44%314.00K

20.91%318.00K

243.52%253.46K

1.89%269.00K

2.64%272.00K

26.44%263.00K

-64.01%73.78K

35.38%264.00K

35.90%265.00K

24.55%208.00K

62.02%205.01K

57.83%195.00K

90.27%195.00K

149.25%167.00K

102.31%126.53K

119.09%123.55K

--102.48K

--67.00K

--62.54K

--56.39K

營業利潤

-915.58%-87.69M

56.39%-5.36M

120.33%1.96M

15.35%-7.54M

16.84%-8.63M

2.91%-12.30M

29.59%-9.63M

21.95%-8.91M

23.19%-10.38M

5.32%-12.67M

8.13%-13.68M

-3.52%-11.42M

-1.27%-13.52M

6.03%-13.38M

-88.58%-14.88M

15.26%-11.03M

-29.55%-13.35M

-13.74%-14.24M

28.08%-7.89M

-28.50%-13.02M

5.84%-10.30M

3.67%-12.52M

-21.73%-10.97M

-42.81%-10.13M

-18.54%-10.94M

-13.72%-12.99M

17.79%-9.02M

44.40%-7.09M

-23.54%-9.23M

-51.91%-11.43M

-5.06%-10.97M

-153.56%-12.76M

-69.32%-7.47M

-124.54%-7.52M

-267.26%-10.44M

-148.59%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

淨非營業利息收入（費用）

利息收入

-20.71%157.00K

5.29%179.00K

-45.52%158.00K

-35.28%222.00K

-53.63%198.00K

-69.75%170.00K

-67.96%290.00K

-51.00%343.00K

-24.29%427.00K

-12.32%562.00K

43.14%905.00K

250.00%700.00K

540.91%564.00K

7912.50%641.00K

16119.65%632.24K

700.00%200.00K

266.67%88.00K

-38.46%8.00K

-0.41%3.90K

-79.67%25.00K

-82.09%24.00K

-93.60%13.00K

-96.43%3.91K

24.24%123.00K

39.58%134.00K

78.07%203.00K

5.48%109.71K

-2.94%99.00K

-43.53%96.00K

--114.00K

297065.71%104.01K

--102.00K

--170.00K

----

--35.00

-100.00%0.00

--0.00

----

--0.00

--32.00

利息費用

-88.89%5.00K

-96.88%4.00K

-66.67%51.00K

-60.11%75.00K

-79.07%45.00K

-46.89%128.00K

-69.82%153.00K

-34.27%188.00K

-7.33%215.00K

-34.86%241.00K

41.30%507.00K

130.65%286.00K

12.62%232.00K

1380.00%370.00K

--358.81K

--124.00K

--206.00K

--25.00K

----

特殊收入（費用）

--24.49M

--10.00K

----

-固定資產出售收益

----

600.00%20.00K

-152.58%-51.00K

----

97.45%-4.00K

--97.00K

--0.00

-100.00%0.00

-942.59%-157.00K

--0.00

-100.00%0.00

--2.00K

--18.63K

--0.00

--258.00K

----

其他非經營性收入（費用）

---90.01M

----

--0.00

100.00%0.00

--0.00

---2.00K

----

672.67%74.00K

-560.00%-23.00K

-196.15%-25.00K

-156.52%-26.00K

-119.48%-12.92K

-94.90%5.00K

1200.00%26.00K

4700.00%46.00K

--66.34K

--98.00K

--2.00K

---1.00K

----

--0.00

----

稅前利潤

-1704.61%-153.07M

57.75%-5.18M

121.96%2.08M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-84.97%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

27.60%-7.89M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-22.18%-10.90M

-43.51%-10.03M

-18.93%-10.83M

-13.77%-12.82M

17.39%-8.92M

44.34%-6.99M

-24.78%-9.11M

-49.77%-11.27M

-3.42%-10.80M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

所得稅

----

--500.00K

----

-100.00%0.00

----

140.00%495.00K

----

41350.00%206.25K

----

-100.06%-500.00

--0.00

--413.00K

----

--825.00K

----

--0.00

----

--0.00

除稅後利潤

-1704.61%-153.07M

57.75%-5.18M

116.69%1.58M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-74.05%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

24.49%-8.38M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-24.50%-11.10M

-43.51%-10.03M

-13.77%-10.83M

-13.77%-12.82M

23.26%-8.92M

44.34%-6.99M

-30.44%-9.52M

-49.77%-11.27M

-11.33%-11.62M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

持續經營利潤

-1704.61%-153.07M

57.75%-5.18M

116.69%1.58M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-74.05%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

24.49%-8.38M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-24.50%-11.10M

-43.51%-10.03M

-13.77%-10.83M

-13.77%-12.82M

23.26%-8.92M

44.34%-6.99M

-30.44%-9.52M

-49.77%-11.27M

-11.33%-11.62M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

歸属于母公司的淨利潤

-1704.61%-153.07M

57.75%-5.18M

116.69%1.58M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-74.05%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

24.49%-8.38M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-24.50%-11.10M

-43.51%-10.03M

-13.77%-10.83M

-13.77%-12.82M

23.26%-8.92M

44.34%-6.99M

-30.44%-9.52M

-49.77%-11.27M

-11.33%-11.62M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

歸屬普通股東的淨利潤

-1704.61%-153.07M

57.75%-5.18M

116.69%1.58M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-74.05%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

24.49%-8.38M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-24.50%-11.10M

-43.51%-10.03M

-13.77%-10.83M

-13.77%-12.82M

23.26%-8.92M

44.34%-6.99M

-30.44%-9.52M

-49.77%-11.27M

-11.33%-11.62M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

基本每股收益

-805.64%-24.14

-19474.79%-32.31

444.72%0.44

56.32%-0.07

56.17%-0.09

33.87%-0.17

55.18%-0.13

28.79%-0.17

31.13%-0.20

14.98%-0.25

23.57%-0.28

23.33%-0.24

21.21%-0.29

32.79%-0.29

-41.92%-0.37

24.90%-0.31

-13.51%-0.37

-6.30%-0.44

28.38%-0.26

-21.87%-0.41

14.27%-0.33

14.83%-0.41

0.71%-0.37

-8.65%-0.34

16.06%-0.38

11.29%-0.48

35.85%-0.37

50.09%-0.31

-26.11%-0.46

-45.04%-0.54

8.30%-0.58

-106.30%-0.62

-86.08%-0.36

-19.04%-0.37

-267.26%-0.63

-148.59%-0.30

---0.19

---0.31

---0.17

---0.12

稀釋每股收益

-805.64%-24.14

-19474.79%-32.31

444.72%0.44

56.32%-0.07

56.17%-0.09

33.87%-0.17

55.18%-0.13

28.79%-0.17

31.13%-0.20

14.98%-0.25

23.57%-0.28

23.33%-0.24

21.21%-0.29

32.79%-0.29

-41.92%-0.37

24.90%-0.31

-13.51%-0.37

-6.30%-0.44

28.38%-0.26

-21.87%-0.41

14.27%-0.33

14.83%-0.41

0.71%-0.37

-8.65%-0.34

16.06%-0.38

11.29%-0.48

35.85%-0.37

50.09%-0.31

-26.11%-0.46

-45.04%-0.54

8.30%-0.58

-106.30%-0.62

-86.08%-0.36

-19.04%-0.37

-267.26%-0.63

-148.59%-0.30

---0.19

---0.31

---0.17

---0.12

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Cue Biopharma Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 CUE 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Cue Biopharma Inc 財年末的營收是多少？



Cue Biopharma Inc 2025 財年營收為 27.47M，高於上一財年的 9.29M。

Cue Biopharma Inc 最近一個季度的營收是多少？



Cue Biopharma Inc 最近一個季度的營收為 7.88M，同比增長 166.66%。

Cue Biopharma Inc 全年的淨利潤是多少？



Cue Biopharma Inc 2025 財年淨利潤為 -26.60M。

Cue Biopharma Inc 上一季度的淨利潤是多少？



Cue Biopharma Inc 最近一個季度的淨利潤為 -153.07M。

Cue Biopharma Inc 年度營業利潤是多少？



Cue Biopharma Inc 2025 財年的營業利潤為 -26.52M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。